Enhanced stability of microtubules enriched in detyrosinated tubulin is not a direct function of detyrosination level by unknown
Enhanced Stability of Microtubules Enriched in Detyrosinated 
Tubulin Is Not a Direct Function of Detyrosination Level 
Sadiqa Khawaja, Gregg  G. Gundersen, and Jeannette Chloi~ Bulinski 
Department of  Biology, University of  California, Los Angeles, California 90024 
Abstract.  Interphase cultured monkey kidney (TC-7) 
cells contain distinct subsets of cellular microtubules 
(MTs) enriched in posttranslationally detyrosinated 
(Glu) or tyrosinated (Tyr) a  tubulin (Gundersen, 
G. G., M.  H. Kalnoski, and J. C.  Bulinski.  1984. 
Cell. 38:779-789).  To determine the relative stability 
of these subsets of MTs, we subjected TO-7 cells to 
treatments that slowly depolymerized MTs. We found 
Glu MTs to be more resistant than Tyr MTs to depoly- 
merization  by nocodazole in living cells, and to depo- 
lymerization by dilution in detergent-permeabilized 
cell models.  However, in cold-treated cells, Glu and 
Tyr MTs did not differ significantly in their stability. 
Digestion of permeabilized cell models with pancreatic 
carboxypeptidase A, to generate Gh MTs from endog- 
enous Tyr MTs, did not significantly alter the resis- 
tance of the endogenous Tyr MTs toward dilution- 
induced depolymerization.  Furthermore,  in human 
fibroblasts that contained no distinct Glu MTs, we ob- 
served a population of nocodazole-resistant MTs. 
These data suggest that Glu MTs possess enhanced 
stability against end-mediated depolymerization, yet 
detyrosination alone appears to be insufficient to con- 
fer this enhanced stability. 
unique posttranslational  modification of a tubulin has 
been described in which a tyrosine residue is rever- 
sibly added to the COOH terminus  (Barra  et al., 
1973, 1974). Two enzymes are involved in these modifica- 
tions: a tubulin tyrosine ligase, which adds a tyrosine residue 
to the COOH terminus (Raybin and Flavin, 1977a; Flavin and 
Murofushi,  1984), and a  tubulin  carboxypeptidase, which 
removes the COOH-terminal tyrosine (Argarana et al., 1978, 
1980). No dramatic  differences have been detected between 
the in vitro behavior of tyrosinated (Tyr) ~  and detyrosinated 
(Glu) tubulin (Raybin and Flavin, 1977b; Kumar and Flavin, 
1982; Arce et al., 1978). Nonetheless, changes in the relative 
levels of  Tyr and Glu tubulin or in the activity of  the enzymes 
carrying out the modifications  occur during differentiation 
(Barra et al., 1973, 1980; Deanin et al., 1977; Nath and Fla- 
vin, 1979; Rodriguez and Borisy, 1978, 1979), during the cell 
cycle (Forest and Klevecz,  1978), and in at least one disease 
condition (Nath et al., 1982). To date, the role of posttransla- 
tional  tyrosination in microtubule (MT)  function has not 
been determined. 
Recently,  we localized  Tyr and  Glu tubulin  in cultured 
cells using antibodies specific for each form of tubulin (Gun- 
dersen et al., I984). Curiously, these two species were found 
to be predominantly segregated  into distinct populations of 
1. Abbreviations  used in this paper: CPA, pancreatic carboxypeptidase  A; 
Glu, detyrosinated; MAP,  microtubule-associated  protein; MT,  microtu- 
bule; PEM buffer,  85 mM Pipes, pH 6.94,  10 mM EGTA,  and 1 mM 
MgCI2; Tyr, tyrosinated. 
microtubules; that is, most MTs contained primarily Tyr tu- 
bulin (Tyr MTs), while a few MTs contained primarily Glu 
tubulin (Glu MTs) (Gundersen  et al.,  1984; Geuens et al., 
1986).  Functional  differences  between Tyr and Glu MTs, 
though not established,  are suggested by the observation that 
Tyr tubulin predominates  in the dynamic MTs of proliferat- 
ing cells, while Glu tubulin predominates  in the stable as- 
semblies of MTs present in differentiated cells, e.g., flagellar 
and ciliary axonemes,  neurites,  and marginal  bands (Gun- 
dersen and Bulinski,  1986a). 
An important  question that arises is whether Glu and Tyr 
MTs exhibit different properties in vivo. Differences  in the 
behaviors of Glu and Tyr MTs would, in turn, imply func- 
tional differences between the different types of MTs. Tyrosi- 
nation/detyrosination  is a feasible mechanism for creating 
functionally  distinct  subsets of MTs,  since in  a  previous 
study we demonstrated  that MTs with biochemically differ- 
ent tubulin subunits were created in vivo by postpolymeriza- 
tion detyrosination (Gundersen et al.,  1987a). In interphase 
cells, most MTs are dynamic, turning  over with a half-life 
of 5-10 min; in contrast,  some MTs appear to exhibit a very 
slow rate of turnover, with a half-life of 1 h or more (Schulze 
and Kirschner,  1986, 1987). The existence of a small popula- 
tion of stable MTs in interphase cells has also been suggested 
by studies using MT-depolymerizing  agents in cultured cells 
(Thompson et al., 1984; Piperno et al., 1987), and in mono- 
cytes (Cassimeris  et al.,  1986). Currently,  both the mecha- 
nism for the stabilization of a small subset of interphase  MTs 
and the functional  significance  of these stabilized  MTs are 
unknown. 
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Glu and Tyr MTs in African green monkey kidney (TC-7) 
cells to three different  depolymerization treatments: nocoda- 
zole  and cold  treatments of intact  cells,  and dilution of 
detergent-extracted cytoskeletons. In addition, we examined 
cells and cytoskeletons with dramatically different levels of 
Glu tubulin in their MTs in order to determine the effect of 
detyrosination on microtubule stability. 
Materials and Methods 
Cell Culture and Treatments 
1"t2-7 cells, an epithelial-like cell line derived from the CV-1 line of African 
green monkey kidney cells, were grown in DMEM supplemented with 10% 
FCS (growth medium), as previously described (Gundersen et al.,  1984). 
Human foreskin fibroblast cells (strain 356) derived by R. De Mars (Univer- 
sity of Wisconsin, Madison, WI), were cultured in F-10 medium supple- 
mented with 10% FCS. Cells were seeded onto glass coverslips in 100-mm 
petri dishes and allowed to grow for 2-3 d before experiments. 
Nocodazole treatments were performed by adding the drug to growth 
medium to achieve a final concentration of  0.2 or 0.6 ltg/ml, using a nocoda- 
zole stock prepared in DMSO (the final DMSO concentration  did not exceed 
0.1%, and this concentration of DMSO had no effect on the stability of Glu 
or Tyr MTs). Cold treatments were performed at 80C, using a circulating 
waterbath (Brinkmarm Instruments Co., Westbury, NY); 8~  was chosen 
since depolymerization at 0*C was too rapid (t~ •1  min) to monitor con- 
veniently. Human 356 cells ~ere treated with 0.3 ttg/ml of nocodazole in 
growth medium for 30, 60, or 90 min, then they were rinsed in nocodazote- 
containing buffer, and immediately fixed in cold methanol. 
Extraction and Fixation 
TC-7 cells from all treatments (except untreated cells in the dilution experi- 
ments, as noted below) were extracted to remove monomeric tubulin, whose 
bright diffuse staining would otherwise obscure MTs. All steps in the extrac- 
tion protocol were performed at 25"C unless noted otherwise. Coverslips 
were rinsed twice in PEM buffer (85 mM Pipes, pH 6.94,  10 mM EGTA, 
and 1 mM MgC12), and then extrac~l for 1 rain with 8 ml of PEM (per 
100-ram dish) containing 0.1  (for nocodazole-treated cells) or 0.5%  (for 
cold-treated cells) Triton X-100. The extraction of nocodazole-treated cells 
was performed in buffer supplemented with nocodazole at the same concen- 
tration as the treatment to prevent repolymefization  of microtubules during 
extraction. Similarly, cold-treated cells were extracted with buffer main- 
tained at 8~  After extraction, cells were rinsed briefly in PEM and fixed 
in methanol (-20~  5 min). 
To examine the stability of Glu and Tyr MTs to dilution-induced depoly- 
merization, cells were extracted with 0.1% Triton X-100 at 25~  as above, 
rinsed twice in PEM, and then incubated in PEM at 37~  for various inter- 
vals before methanol fixation. For some experiments, extracted ceils were 
rinsed to remove the Triton X-100 and then treated with 50 I.tg/ml of carbox- 
ypeptidase A (CPA; Cooper Biomedical, Inc., Malvern, PA) for 5 min at 
37~  in PEM buffer. The CPA-treated cytoskeletons were rinsed twice with 
PEM and further incubated in PEM buffer at 37~  before methanol fixation. 
Indirect lramunofluorescence 
Double-indirect immunofluorescence was performed as described (Gun- 
dersen et al.,  I987a) except that the Glu and Tyr antibodies were used at 
1:I00 dilutions. The Glu antibody was a rabbit polyclonal peptide antibody 
specific for Glu tubulin (Gundersen et al., 1984) and the Tyr antibody was 
a rat monoclonal antibody (YL 1/2) specific for Tyr tubulin (Kilmartin et 
al.,  1982; Wehland et al.,  1983).  YL 1/2 was generously provided by Dr. 
L  V. Kilmartin (Medical Research Council, Cambridge, England). Total 
cellular tubulin was visualized by staining with a mouse monoclonal anti- 
body specific for I~ tubulin (designated 3F3) at 1:100 dilution of ascites fluid 
(Moyer et al., 1986). 3F3 was kindly provided by Dr. J. Lessard (University 
of Cincinnati, Cincinnati, OH).  Secondary antibodies were fluorescein- 
conjugated goat anti-rat IgG, rhodamine-conjugated goat anti-rabbit IgG, 
and fluorescein-conjugated goat anti-mouse IgG (obtained from Cooper 
Biomedical, Inc.) and were used at t:20 dilutions. No difference was ob- 
served if the fuorochromes on each secondary antibody were switched. 
Incubations with Glu and Tyr antibodies or Glu and 3F3 antibodies were 
performed simultaneously, as were subsequent incubations with the second- 
ary antibodies. 
Quantxfication of  Microtubules 
Cells stained as above were examined with a Nikon epifluorescence micro- 
scope equipped with the appropriate filters for ffuorescein and rhodamine 
fuorescence. Images were recorded on 35  mm Kodak Tri-X  film using a 
40￿  (1.0 NA) or a 63x  (1.4 NA) Zeiss planapochromat lens and exposure 
times of 4-16 s. The film was developed to ASA 400 with HC-110 developer 
and negatives were printed at a magnification of 870 (about twice the mag- 
nification of the figures in Results). The number of Glu and Tyr MTs per 
cell was determined by tracing individual Glu- (or Tyr-) stained MTs visible 
on photographic prints onto acetate sheets and then counting the traces. All 
coverslips were stained with the same preparations of Glu and Tyr antibod- 
ies, at the same concentration of antiserum. Thus, consistent criteria were 
used to identify and count Glu and Tyr MTs in each cell and preparation 
of cells examined. 
For each time point, we determined the number of Glu and Tyr MTs in 
30-44 randomly chosen cells. The mean from two or three separate experi- 
ments was then used to prepare the curves in Results. Certain cells were ex- 
cluded from analysis because of either their unusual MT number (giant, 
multinucleated cells), or their known lack of Glu MTs (early G~ cells still 
connected by midbodies or early prophase cells with split centrosomes and 
condensing chromatin) (Gundersen and Bulinski,  1986b). 
Results 
MTs  containing Glu  tubulin  are  generated  by  the  post- 
polymerization detyrosination  of  Tyr MTs (Gundersen et al., 
1987a). Thus, long-lived MTs would be expected to contain 
a relatively high content of Glu tubulin when compared with 
short-lived MTs. This prediction is borne out by the elevated 
levels  of Glu tubulin in stable assemblies of MTs  in both 
proliferating and differentiated cells (Gundersen and Bulin- 
ski, 1986a). An important question is whether the detyrosi- 
nation of MTs contributes to their stability or whether it is 
merely a consequence of the stability induced by other fac- 
tors. We sought to test this question by examining the stabil- 
ity of Glu and Tyr MTs in vivo to a variety of treatments that 
depolymerize MTs. 
We have used the interphase array of MTs in TC-7 cells, 
an epithelial-like cell line, as the source of MTs, since these 
cells contain well-defined, co-existing populations of Glu 
and Tyr MTs in their cytoplasm (Gundersen et al.,  1984, 
1987a). Although there is probably a continuum of different 
levels of Glu and Tyr tubulin in cellular MTs (Geuens et al., 
1986),  by double immunofluorescence some MTs in TC-7 
cells  stain  only  with  a  Glu-specific  antibody  (these  are 
termed Glu MTs), while others stain only with a Tyr-specific 
antibody  (these  are  termed Tyr MTs;  Gundersen et  al., 
1984). In both cases, the lack of immunofluorescent staining 
presumably indicates that the level of that species is too low 
to be detected. A third class of MTs are those that exhibit im- 
munofluorescent  staining  with  both  antibodies  (Glu-Tyr 
MTs). Ideally, it would be interesting to determine the stabil- 
ity of each of these three classes; however,  because of the 
difficulty of accurately counting MTs in cells, we have re- 
stricted our study to a comparison between MTs that stain 
with the Tyr antibody (Tyr and Glu-Tyr MTs) and those that 
stain with the Glu antibody (Glu and Glu-Tyr MTs). For con- 
venience, in the remainder of the paper we will refer to these 
two categories as Tyr and Glu MTs, respectively. 
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by Nocodazole Treatment 
Tyr and Glu MTs in TC-7 cells can be completely depolymer- 
ized by prolonged treatment with moderate concentrations of 
nocodazole  (Gundersen  et  al.,  1987a).  However,  if lower 
concentrations of nocodazole are used,  MTs depolymerize 
slowly, allowing the number of Tyr and Glu MTs to be deter- 
mined at various times of treatment. Fig.  1, A and B, show 
the distributions of Tyr and Glu MTs, respectively, in a typi- 
cal field of untreated cells. After a 15-rain treatment with 0.2 
p.g/ml nocodazole, both types of MTs were clearly reduced 
in number (Fig. 1, C and D). With longer treatments, further 
MT breakdown occurred,  so that by 90  min only a  small 
number of MTs remained in each cell (Fig.  1, E and F). De- 
terminations of the number of Tyr and Glu MTs in 10 repre- 
sentative cells at each of three time points are shown in Table 
I. The individual MT counts for both Tyr and Glu MTs var- 
ied  substantially;  however,  it  is  clear that  the  nocodazole 
treatment decreased the number of Tyr MTs more rapidly 
than it decreased the number of Glu MTs. This is even more 
evident in Fig. 2 A, in which the data from three experiments 
such as the one shown in Table I have been presented graphi- 
cally. At each time point of nocodazole treatment, we have 
plotted  the  average number of Tyr and  Glu  MTs that  re- 
mained. The two curves show a 20-30% difference between 
the proportion of each type of MTs that remained at each 
time point. This difference was largely due to the rapid depo- 
lymerization of some Tyr MTs (~50%  in the first 20 min); 
the remaining Tyr MTs depolymerized at an approximately 
constant rate, a rate equivalent to that characteristic of all Glu 
MTs. 
Figure 1.  Distribution  of Tyr 
and  Glu  tubulin  in  nocoda- 
zole-treated  TC-7 cells.  Cells 
were  treated  with  0.2  ~tg/ml 
nocodazole  for the  indicated 
times and then Triton-extract- 
ed,  fixed,  and  stained  with 
Tyr and Glu antibodies as de- 
scribed in Materials and Meth- 
ods. Distribution of Tyr tubu- 
lin  (A,  C,  and  E)  and  Glu 
tubulin (B, D, and F) in cells 
before  nocodazole  treatment 
(A and B), after 15 min (Cand 
D), and after 90 min (E and 
F)  of nocodazole  treatment. 
Bar, 5 Ixm. 
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Cell number 
Treatment  MT 
time  type  1  2  3  4  5  6  7  8  9  10 
rain 
0  Tyr  61  80  68  100  89  80  79  81  85  110 
Glu  3  4  14  32  32  22  29  31  39  28 
15  Tyr  21  38  46  26  50  46  36  61  70  49 
Glu  0  37  28  6  18  32  15  20  0  35 
90  Tyr  2  18  0  7  4  8  0  2  6  6 
Glu  3  20  0  7  3  8  0  2  8  4 
TC-7 cells were treated  with nocodazole (0.2 Ixg/ml) as described in Materials 
and Methods. Tyr and Glu MT counts for 10 representative ceils are shown 
for each of the treatment times that are shown in the immunofluorescenee 
micrographs in Fig.  1. 
In untreated cells, MTs stained only with the l~yr antibody 
comprise the largest subset of  MTs (see Fig. 1, A andB; also, 
Gundersen et al.,  1984,  1987a). However, after prolonged 
treatment with nocodazole, this class of MTs was almost 
completely absent (see Fig.  1, E and F,, and Table I). In fact, 
at the 90-min timepoint 95 % of the MTs that remained were 
stained with both antibodies. This is an important result be- 
cause it suggests that Tyr MTs that possess a significant level 
of Glu subunits (i.e., those detectable with our Glu antibody) 
are more stable than those that do not have detectable Glu 
subunits. 
The above experiments suggest that Glu MTs are more sta- 
ble than Tyr MTs. However, there is an alternative explana- 
tion. Glu MTs are generated by postpolymerization  detyrosi- 
nation ofTyr MTs in as little as 20-25 min and all (Tyr) MTs 
appear to be susceptible to this conversion (Gundersen et al., 
1987a). Thus, the stable Glu MTs we observed in treated cells 
could be attributable to either a population of stable Glu MTs 
that was present at the time of nocodazole addition, or to a 
stable population of Tyr MTs that was detyrosinated during 
the nocodazole treatment. To distinguish between these two 
possibilities, we treated cells with a higher concentration of 
nocodazole (0.6 ~tg/ml), so that MT depolymerization would 
proceed more quickly (Fig. 2 B). Tyr MT depolymerization 
was biphasic, as it had been with the lower concentration of 
nocodazole: •50%  ofTyr MTs depolymerized rapidly while 
the  remainder disassembled  more slowly and at approxi- 
mately the  same  rate as  the Glu MTs.  Most importantly, 
while 40% of the Tyr MTs were disassembled during a 2-min 
treatment, only 4 % of the Glu MTs were depolymerized dur- 
ing this treatment. Since Glu MTs could not be created by 
detyrosination within such a short time, this result confirms 
the previous suggestion that Glu MTs are more stable to de- 
polymerization by nocodazole than are Tyr MTs. 
In Vivo Depolymerization of  MT Subsets 
in Cold-treated Cells 
To determine if Glu MTs were more stable than Tyr MTs to 
other  depolymerizing agents,  we  treated  cells  with  cold 
(8~  for various times. As shown in Fig. 3, quantification 
of the number of MTs remaining after various times of cold 
treatment showed that the rate of depolymerization of "13tr 








-~  8o 
:3 
t~ 




1  J  J  l  I  1,  ~  I  t  t 
0  0  20  40  60  80 
Time  (rain) 
Figure 2. Time course of Tyr and Glu MT depolymerization by 
nocodazole treatment. TC-7 cells treated with 0.2 (A) or 0.6 Ixg/mi 
nocodazole (B). The percentages of microtubules per cell that re- 
main at each time are plotted: (o) Tyr MTs; (o) Glu MTs. Each 
determination represents the average number of MTs + SEM from 
30 ceils. 
in both types of MTs was observed by 5 min of treatment, 
and this was followed by a slower decrease in which both Tyr 
and Glu MTs were lost at parallel rates. MTs in cold-treated 
cells  showed more uniform behavior than those in drug- 
treated cells (compare errors in the measurements shown in 
Fig. 3 with those in Fig. 2). There was only a slight differ- 
ence in the proportion of Tyr and Glu MTs remaining after 
60 min of cold treatment (14 vs.  18 %, respectively). These 
results suggest that there is no significant difference in the 
behavior of Tyr and Glu MTs toward cold-induced depoly- 
merization. 
Stability of Tyr and Glu MTs to Dilution-induced 
Depolymerization 
As  a  third  test of the  stability of Tyr and Glu MTs,  we 
detergent-extracted cells  and  then incubated the  resultant 
cytoskeletons in PEM buffer (see Materials and Methods). 
120 
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Time  (rain) 
Figure 3. Time course of  Tyr  and Glu MT depolymerization by cold 
(8~  treatment of TC-7 cells. The percentages of microtubules per 
cell that remain at each time point are plotted: (o) Tyr MTs; (o) 
Glu MTs. Each determination represents the average number of 
MTs +  SEM from 30 cells. 
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Figure 4. Time course of Tyr, Glu, and exogenous Glu MT disas- 
sembly after extraction and dilution of the monomer pool. Some 
extracted cells were treated with CPA to generate Glu MTs (exoge- 
nous Glu MTs). TC-7 cells were Triton-extracted and  then in- 
cubated in buffer to dilute the monomer pool. The percentages of 
microtubules per cell that remain at each time are plotted: (o) Tyr 
MTs; (o) Glu MTs; (<9) exogenous Glu MTs (MTs in CPA-treated 
cytoskeletons). Each determination represents the average number 
of MTs  +  SEM from 44 cells. 
This  induces  depolymerization of MTs  by dilution  of the 
protomer pool. Quantification showed that there was a sig- 
nificant difference  in  the  sensitivity  of Tyr and  Glu  MTs 
to dilution (Fig.  4).  A  comparison of extracted and unex- 
tracted cells revealed that the extraction itself resulted in a 
decrease of ~20% in the number ofTyr MTs, but no detect- 
able decrease in Glu MTs. During the incubation of extracted 
cells, Tyr MTs disassembled rapidly,  so that by 10 min after 
extraction <50% of the Tyr MTs remained (Fig. 4). In con- 
trast, <20% of the Glu MTs disassembled during the first 10 
min of incubation (Fig.  4).  With longer incubations,  both 
types of MTs decreased in parallel,  with ~25 % lost every 
10 min. 
As  in  nocodazole  treatment  there  appeared  to  be  two 
classes  of Tyr MTs:  labile  ones that depolymerized more 
rapidly  than  Glu  MTs,  and  more  resistant  ones  that  de- 
polymerized with a rate similar to that of Glu MTs.  Also, 
similar to the results  from nocodazole treatment, the more 
resistant class of Tyr MTs was comparatively enriched in 
MTs that stained with both antibodies. Whereas the propor- 
tion ofTyr MTs stained with the Glu antibody was <20% in 
untreated cells, it was >80% in extracted cells incubated for 
80 min. Unlike the Tyr MTs,  Glu MTs appeared to depoly- 
merize as one class, with a constant rate of loss throughout 
the dilution experiment. 
Stability of  ExperimentaUy Generated Glu MTs 
The experiments described above show that MTs containing 
Glu tubulin  are  more  stable  to nocodazole- and  dilution- 
induced depolymerization. To test  whether the stabilization 
of Glu MTs toward  nocodazole and dilution was conferred 
by the presence of Glu subunits in the MTs, we created Glu 
MTs  from the  endogenous Tyr MTs  by treating  extracted 
cytoskeletons  with  CPA.  CPA  treatment  results  in  the 
detyrosination of  preexisting Tyr MTs in fixed cells (Gunder- 
sen et al.,  1984) and we found that unfixed TC-7 cytoskele- 
tons could be almost completely detyrosinated by CPA treat- 
Figure 5.  Distribution of Tyr 
and Glu tubulin in CPA-treat- 
ed  cytoskeletons. Cytoskele- 
tons were prepared from TC-7 
cells by Triton extraction and 
then incubated with (A, B, and 
D) or without CPA (C) for 5 
min. Distribution of Tyr (A) 
and Glu (B) tubulin, showing 
the complete  conversion  of  Tyr 
tubulin by the 5-min CPA treat- 
ment.  Distribution of  total 
tubulin in untreated (C) and 
CPA-treated (D) cytoskeletons 
after depolymerization  was in- 
duced by dilution in buffer for 
50 min. Bar, 5 gm. 
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1,  A  and B).  Immunoblots of CPA-digested cytoskeletons 
showed that Tyr tubulin comprised <10 % of the total tubulin, 
while the level of Tyr tubulin in undigested cytoskeletons is 
/>90% (Gundersen et al.,  1987a). Thus, this brief CPA treat- 
ment generates MTs that, on the average, have greater than 
nine times as much Glu tubulin as the endogenous Tyr MTs. 
To  distinguish  Glu  MTs  created  by  CPA  treatment  from 
preexisting,  endogenous  Glu  MTs,  we  will  refer  to  the 
former as "exogenous Glu MTs" 
Exogenous Glu MTs were indistinguishable from Tyr MTs 
in their resistance to dilution, as shown quantitatively in Fig. 
4 and in the micrographs in Fig. 5, Cand D. This is an impor- 
tant result since it suggests that factors other than the pres- 
ence of Glu subunits  within  a  MT are responsible for the 
stabilization of endogenous Glu MTs. Because this experi- 
ment requires extraction of cells under conditions that re- 
move endogenous MAPs (data not shown), our results do not 
rule out the possibility that a  stabilizing MAP,  specific for 
Glu tubulin, is responsible for enhancing the stability of en- 
dogenous Glu MTs (see Discussion). 
MT Stability in Cells that Do Not Contain Glu MTs 
Although most cultured cell lines and strains we have exam- 
ined contain a population of Glu MTs, some have very few 
detectable Glu MTs. We examined one of these (the human 
fibroblast cell strain, 356) to determine if cells that lack Glu 
MTs contain stable MTs. These cells do contain Glu tubulin 
as judged by immunoblots (Webster et al.,  1987a),  yet only 
Figure 6.  Distribution  of Tyr 
and  Glu  tubulin  in  nocoda- 
zole-treated 356 cells.  Distri- 
bution of Tyr (A and C) and 
Glu (B and D) tubulin in cells 
before  nocodazole  treatment 
(A and  B)  and  after 90 min 
of treatment  with  0.3  I~g/ml 
nocodazole  (C and  D).  Bar, 
5 I.tm. 
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level to be visualized using our immunofluorescence pro- 
tocol (Fig. 6, A and B). In 356 cells treated with 0.3 ~g/ml 
of nocodazole most MTs depolymerized rapidly, but a small 
population of MTs in every cell was not depolymerized by 
even a 90-min nocodazole treatment (Fig. 6 C). As expected, 
these drug-stable MTs were not detectable with Glu antibody 
(Fig. 6 D). This result extends our analysis of the relation- 
ship of Glu level and MT stability: stability of a subset of cel- 
lular MTs neither requires nor results from a high level of 
Glu subunits. 
Discussion 
The experiments reported in this paper demonstrate that, 
when  compared  with  MTs  enriched  in  Tyr tubulin  (Tyr 
MTs), cellular MTs enriched in Glu tubulin (Glu MTs) pos- 
sess a greater stability against depolymerization by nocoda- 
zole or dilution of the monomer pool.  However, Glu MTs 
showed no enhanced stability relative to Tyr MTs in cold 
treatments. The enhanced stability of interphase Glu MTs is 
consistent with the correlation we described previously in 
differentiated cells  (Gundersen and Bulinski,  1986a);  Glu 
tubulin levels were elevated in the unusually stable MTs of 
axonemes, neurites, marginal bands, centrioles, and primary 
cells. 
In evaluating the differences in MT stability that we have 
measured, it is important to consider sources of  experimental 
errors,  namely,  in  our  counts  of cellular  MTs.  We  have 
counted  single  immunofluorescent fibers;  however,  many 
fibers may be too closely apposed to be resolved at the light 
microscopic level. This sort of error would serve to decrease 
our counts of Tyr MTs,  especially in untreated cells or at 
early times in the depolymerizing treatment, since the dense 
array of straight Tyr MTs present near the centrosome is 
difficult to resolve into single fibers. The counts of Glu MTs 
would be expected to be a more accurate measure since fewer 
Glu MTs were present, and the sparse array of curly MTs 
could be resolved into distinct fibers quite readily. At later 
time points when few MTs remain, counts of both Glu and 
Tyr fibers would be expected to be accurate. In all of our 
counts, we have assumed that stained fibers correspond to 
single  MTs  rather than bundles of Glu or Tyr MTs;  this 
assumption  has  been  supported  by  electron  microscopic 
studies in which no bundles of either Glu or Tyr MTs were 
observed (Geuens et al., 1986). An additional counting error 
stems from the protocol we used for fixation of the cells: To 
remove protomeric tubulin, which would have obscured the 
MTs, we extracted the cells with Triton X-100 before we fixed 
them. In untreated cells, this extraction markedly decreased 
the number of Tyr MTs, as compared with cells fixed with- 
out prior extraction; extraction had no effect on the number 
of Glu MTs present. Thus, both the dense packing of MTs and 
the extraction probably gave rise to an underestimate in the 
number of Tyr MTs at t =  0 in each treatment. These errors 
alter our results only quantitatively; had errors in the Tyr MT 
counts been avoided, the difference in stability between Tyr 
and Glu MTs would have been even more dramatic than the 
difference we measured. 
One possible explanation for the difference in stability we 
observed between Glu and Tyr MTs in vivo is that the high 
content of Glu tubulin in a MT could itself confer enhanced 
stability.  This explanation was rendered unlikely by our find- 
ing that the dilution stability of detergent-extracted cytoskel- 
etons was  identical whether or not the cytoskeletons were 
pretreated with carboxypeptidase A to substantially increase 
the Glu level in all MTs. Moreover, we determined that in 
human fibroblast cells in which no MTs possessed a high 
level of Glu tubulin,  a  significant population of MTs was 
resistant to drug treatment. These results are in agreement 
with previous in vitro comparisons of Glu/Tyr tubulin mix- 
tures (Arce et al., 1978; Raybin and Flavin, 1976; Kumar and 
Flavin,  1982),  supporting the contention that  Glu tubulin 
content alone is neither necessary nor sufficient to stabilize 
MTs. Rather, high Glu tubulin content in a MT is more likely 
to be the result of stability conferred on that MT by another, 
as yet unknown, means. 
Our finding that tubulin detyrosination does not have a di- 
rect effect on MT stability raises the question of what is caus- 
ing the enhanced stability of this MT subset. Three mecha- 
nisms come to mind: alterations in the complement of MAPs 
(especially Glu-specific MAPs), other time-dependent post- 
translational modifications, or capping of MT ends. To date, 
no evidence of a heterogeneous distribution of MAPs exists 
in undifferentiated cells, though perhaps only the more prev- 
alent (or universal) MAPs have thus far been studied.  Glu 
MTs could be stabilized by Glu-specific- or -selective-bind- 
ing proteins; however, no MAPs with this behavior have been 
described to date, and a subset of Tyr MTs (which presum- 
ably contain a low level of Glu tubulin and a correspondingly 
low level of any Glu-specific MAP) was also found to be sta- 
ble in our study.  Finally, MAPs are unlikely to be the only 
effectors of MT stability in vivo, since in our dilution experi- 
ment at least the predominant TC-7 cell MAP, primate 210K 
MAP (Bulinski and Borisy, 1980),  was extracted, yet these 
cytoskeletal preparations still exhibited a stable MT subset. 
Another posttranslational modification of  tubulin, acetyla- 
tion, might seem to be a good candidate for stabilizing MTs, 
though results demonstrating acetylation of tubulin in stable 
MT  subsets  (LeDizet and  Piperno,  1986;  Piperno et al., 
1987) may reflect an effect rather than a cause of stability.  We 
note, however, that early in the formation of MTs after re- 
lease from nocodazole, small segments of acetylated tubulin 
appear on some MTs (Bulinski et al.,  1988); these segments 
could be responsible for alterations in MT stability.  Still, no 
definitive studies have examined the cause and effect relation- 
ship between tubulin acetylation and MT stability. 
A final mechanism that could explain the stabilization of 
MTs is capping of the growing ends, such that subunit addi- 
tion and loss are restricted. Though in interphase cultured 
cells nearly all MTs are either growing or shrinking (Soltys 
and Borisy, 1985; Schulze and Kirschner, 1986), a small sub- 
set of MTs does not appear to add or lose subunits for several 
hours (Schulze and Kirschner, 1987; Webster et al.,  1987b). 
In other organisms,  there is precedent for the capping of 
growing  MT  ends.  For example,  the  central  MTs  in  the 
ciliary axoneme of Tetrahymena are attached to a structure 
at the distal tip of the cilium (Dentler, 1984). In the mitotic 
spindle of cultured cells, MTs originating from the spindle 
pole (centrosome) can be capped at their growing ends by in- 
teraction with  the  kinetochore (Mitchison and  Kirschner, 
1985). Currently, there is no direct evidence that MTs of the 
interphase array of proliferating cells are capped or that they 
are attached to a regular structure such as the kinetochore. 
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tained in other recent studies, are most consistent with the 
idea of MT capping in interphase cells. In our study we found 
that Glu MTs were more resistant to drugs or dilution, which 
are both thought to be end-mediated processes,  but not to 
cold  treatment.  Mandelkow  and  Mandelkow  (1985)  have 
shown with cryoelectron microscopy that MTs subjected to 
temperatures ~<I0~  were fragmented at sites along the wall 
of the MT, i.e., they did not exhibit depolymerization exclu- 
sively at their ends.  Thus,  the differential  stability of Glu 
MTs to drugs or dilution, but not cold, can be explained by 
postulating caps on Glu MTs.  Additional evidence for cap- 
ping of Glu MTs is that Glu MTs do not add either endoge- 
nous or microinjected tubulin protomers to their distal ends, 
i.e., they are not growing (Gundersen et al., 1987b; Webster 
et al.,  1987b).  The inability of Glu MTs to add additional 
protomers, like the differential stability of Glu MTs, is most 
simply explained by the presence of a cap on the end of the 
MT. 
It is important to make a distinction between the type of 
capping factor we envision, that is, one that interacts with the 
distal end of the MT to block further subunit addition or loss, 
and the previously described cap of GTP subunits (Carlier 
and Pantaloni,  1981; Hill and Carlier,  1983; Mitchison and 
Kirschner,  1984).  If a GTP cap exists in vivo,  it would be 
present on rapidly growing MTs (Tyr MTs), rather than on 
the nongrowing Glu MTs. Thus, end-mediated stabilization 
of Glu MTs probably does not involve a GI'P cap. 
In summary, we have shown that Glu MTs are more stable 
than Tyr MTs, and have shown that enrichment of Glu tubu- 
lin itself is insufficient to confer differential stability to MTs. 
We have not answered the question of how detyrosination of 
MTs affects the behavior of MTs. The generation of Glu tubu- 
lin in MTs may permit the binding of specific MAPs; in this 
case, postpolymerization detyrosination may serve as a sig- 
nal of MT stability.  Further studies will be necessary to de- 
termine  the function of this posttranslational modification 
and to identify the factor(s) that contribute to the unusual sta- 
bility of the Glu-enriched subset of cellular MTs. 
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